Valsartan-induced hepatotoxicity in a HBs-Ag-Positive patient.
Kiykim
Ahmet
A
Altintas
Engin
E
Sezgin
Orhan
O
Sezer
Kerem
K
Tiftik
Naci
N
Akbay
Esen
E
Seyrek
Ertugrul
E
Konca
Kamuran
K
D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D005260:Female; D006514:Hepatitis B Surface Antigens; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008875:Middle Aged; D013777:Tetrazoles / Q000009:adverse effects* / Q000627:therapeutic use; D014633:Valine / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
D000959:Antihypertensive Agents; D006514:Hepatitis B Surface Antigens; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine